St. Jude Gets FDA, EU Approvals of Neurostimulator for Chronic Pain

St. Jude Medical received FDA and CE Marking approvals of EonC, an extended-life, nonrechargeable primary cell neurostimulator used to treat chronic pain.

Neurostimulators treat neuropathic pain of the trunk and limbs or pain from failed back surgeries. Similar to cardiac pacemakers, the devices deliver mild electrical pulses to the spinal cord, interrupting or masking transmission of pain signals to the brain.

The product allows patients to adjust therapy strength in up to eight pain areas and provides a constant current that automatically adjusts power to deliver consistent therapy over time. It also features the greatest battery capacity of any primary cell neurostimulator, which may reduce the frequency of device replacement procedures, according to St. Jude.